Efficient decellularization of human fetal kidneys through optimized SDS exposure.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
16 Sep 2024
Historique:
received: 21 05 2024
accepted: 02 09 2024
medline: 16 9 2024
pubmed: 16 9 2024
entrez: 15 9 2024
Statut: epublish

Résumé

Chronic kidney disease poses a significant threat to public health. Renal replacement therapy is the primary treatment option for end-stage kidney disease. However, there is a promising and relatively new method in regenerative medicine for creating a functional organ known as whole kidney decellularization. This method uses the intrinsic vasculature to perfuse the decellularizing agent into the tissue, effectively penetrating and removing cellular material. The regenerated bioscaffolds could serve as a source of organ donation. This study is focused on evaluating the effectiveness of various SDS exposures in decellularizing human fetal kidneys. The study included human fetal kidneys harvested from fetuses terminated before 14 weeks of gestational age. Kidneys were divided into six treatment groups based on SDS concentration and duration of perfusion. Decellularization, scanning electron microscopy, histopathological staining, immunofluorescent staining, and immunohistochemistry staining were performed to evaluate the adequacy of the process. The statistical analysis revealed that the SDS 0.1% treatment group had the highest collagen deposition after 24 h, significantly greater than the SDS 0.5% treatment group at 24 and 48 h. No significant differences were observed among the other treatment groups. The study concludes that the SDS 0.1% treatment group for 24 h was the most effective in terms of ECM content preservation and effective cell removal. This treatment showed better results than the other treatment groups and can be considered for future whole kidney decellularization studies.

Identifiants

pubmed: 39278961
doi: 10.1038/s41598-024-71973-4
pii: 10.1038/s41598-024-71973-4
doi:

Substances chimiques

Sodium Dodecyl Sulfate 368GB5141J
Collagen 9007-34-5
Decellularized Extracellular Matrix 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

21545

Subventions

Organisme : Vice-Chancellor for Research of Tehran University of Medical Sciences
ID : 1401-4-468-64142).

Informations de copyright

© 2024. The Author(s).

Références

Prevention C for DC and. Chronic kidney disease in the United States, 2019. In Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention 3 (2019).
2023_USRDS_ADR.
Kovesdy, C. P. Epidemiology of chronic kidney disease: An update 2022. Kidney Int. Suppl. (2011) 12(1), 7–11 (2022).
Neishabouri, A., Soltani Khaboushan, A., Daghigh, F., Kajbafzadeh, A.-M., Majidi Zolbin, M. Decellularization in tissue engineering and regenerative medicine: Evaluation, modification, and application methods. Front. Bioeng. Biotechnol. 10, 805299 (2022).
Haeublein, G. et al. Human endothelial cell seeding in partially decellularized kidneys. Biomed. Res. Int. 2022, 1–8 (2022).
doi: 10.1155/2022/9018074
Hsu, C.-Y. et al. Kidney bioengineering by using decellularized kidney scaffold and renal progenitor cells. Tissue Cell 74, 101699 (2022).
doi: 10.1016/j.tice.2021.101699 pubmed: 34891081
Kajbafzadeh, A.-M. et al. Whole organ sheep kidney tissue engineering and in vivo transplantation: Effects of perfusion-based decellularization on vascular integrity. Mater. Sci. Eng. C 98, 392–400 (2019).
doi: 10.1016/j.msec.2019.01.018
Kajbafzadeh, A.-M., Khorramirouz, R., Kameli, S. M. & Nabavizadeh, B. Microsurgical anastomosis of renal vasculature in rats: A practical platform for acellular kidney transplantation. J. Pediatr. Urol. 14(2), 194–195 (2018).
doi: 10.1016/j.jpurol.2018.01.008 pubmed: 29454630
Destefani, A. C., Sirtoli, G. M., Nogueira, B. V. Advances in the knowledge about kidney decellularization and repopulation. Front. Bioeng. Biotechnol. 5 (2017).
Ko, I. K. et al. Enhanced re-endothelialization of acellular kidney scaffolds for whole organ engineering via antibody conjugation of vasculatures. Technology (Singap World Sci) 02(03), 243–253 (2014).
He, M., Callanan, A., Lagaras, K., Steele, J. A. M. & Stevens, M. M. Optimization of SDS exposure on preservation of ECM characteristics in whole organ decellularization of rat kidneys. J. Biomed. Mater. Res. B Appl. Biomater. 105(6), 1352–1360 (2017).
doi: 10.1002/jbm.b.33668 pubmed: 27062181
Simmons, M. N., Schreiber, M. J. & Gill, I. S. Surgical renal ischemia: A contemporary overview. J. Urol. 180(1), 19–30 (2008).
doi: 10.1016/j.juro.2008.03.022 pubmed: 18485395
Zidde, D. H., Sampaio, F. J. B., de Souza, P., de Souza, D. B. & Pereira-Sampaio, M. A. Anatomical background of ovine kidney for use as animal model: Analysis of arterial segmentation, proportional volume of each segment and arterial injury after cranial pole partial nephrectomy. Int. Braz. J. Urol. 46(6), 1021–1028 (2020).
doi: 10.1590/s1677-5538.ibju.2019.0842 pubmed: 32822132 pmcid: 7527108
Fabian Alejandro, G., Luis Ernesto, B., Hernando Yesid, E. Morphological characterization of the renal arteries in the pig. Comparative analysis with the human. Int. J. Morphol. 35(1), 319–324 (2017).
Sampaio, F. J. B., Pereira-Sampaio, M. A. & Favorito, L. A. The pig kidney as an endourologic model: Anatomic contribution. J. Endourol. 12(1), 45–50 (1998).
doi: 10.1089/end.1998.12.45 pubmed: 9531151
Pereira-Sampaio, M., Favorito, L. A., Henry, R. & Sampaio, F. J. B. Proportional analysis of pig kidney arterial segments: Differences from the human kidney. J. Endourol. 21(7), 784–788 (2007).
doi: 10.1089/end.2006.0318 pubmed: 17705772
Simões, M. et al. Histomorphometric comparison of the human, swine, and ovine collecting systems. Anat. Rec. 299(7), 967–972 (2016).
doi: 10.1002/ar.23360
Bongolan, T., Whiteley, J., Castillo-Prado, J. et al. Decellularization of porcine kidney with submicellar concentrations of SDS results in the improved retention of ECM proteins required for the adhesion and maintenance of human adult renal epithelial cells. Biomater. Sci. 10, 2972–2990 (2022).
Orlando G, Booth C, Wang Z et al. Discarded human kidneys as a source of ECM scaffold for kidney regeneration technologies. Biomaterials. 34, 5915–5925 (2013).
Peloso, A., Petrosyan, A., Da Sacco, S. et al. Renal extracellular matrix scaffolds from discarded kidneys maintain glomerular morphometry and vascular resilience and retains critical growth factors. Transplantation. 99 (2015).
García-Gareta, E. et al. Decellularised scaffolds: Just a framework? Current knowledge and future directions. J. Tissue Eng. 11, 2041731420942903 (2020).
doi: 10.1177/2041731420942903 pubmed: 32742632 pmcid: 7376382
Daryabari, S. S. et al. Development of an efficient perfusion-based protocol for whole-organ decellularization of the ovine uterus as a human-sized model and in vivo application of the bioscaffolds. J. Assist. Reprod. Genet. 36, 1211–1223 (2019).
doi: 10.1007/s10815-019-01463-4 pubmed: 31093867 pmcid: 6603122
Mirmoghtadaei, M. et al. Kidney tissue engineering in preclinical models of renal failure: A systematic review and meta-analysis. Regener. Med. 17(12), 941–955 (2022).
doi: 10.2217/rme-2022-0084
Caralt, M. et al. Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation. Am. J. Transplant. 15(1), 64–75 (2015).
doi: 10.1111/ajt.12999 pubmed: 25403742
Wang, Y., Bao, J., Wu, Q. et al. Method for perfusion decellularization of porcine whole liver and kidney for use as a scaffold for clinical-scale bioengineering engrafts. Xenotransplantation. 22, 48–61 (2014).
Salti, H., Kramer, L., Nelz, S.-C. et al. Decellularization of precision-cut kidney slices—Application of physical and chemical methods. Biomed. Mater. 18, 025004 (2023).
Hussein, K., Saleh, T., Ahmed, E. et al. Biocompatibility and hemocompatibility of efficiently decellularized whole porcine kidney for tissue engineering: Biocompatibility of decellularized kidney. J. Biomed. Mater. Res. A. 106, 2034–2047 (2018).
Sauter, J., Degenhardt, H., Tuebel, J. et al. Effect of different decellularization protocols on reendothelialization with human cells for a perfused renal bioscaffold of the rat. BMC Biotechnol. 23 (2023).
Manalastas, T. M., Dugos, N., Ramos, G., Mondragon, J. M. Effect of decellularization parameters on the efficient production of kidney bioscaffolds. Appl. Biochem. Biotechnol. 193 (2021).
Taylor, D. A. et al. Characterization of perfusion decellularized whole animal body, isolated organs, and multi-organ systems for tissue engineering applications. Physiol. Rep. 9(12), e14817 (2021).
doi: 10.14814/phy2.14817 pubmed: 34184419 pmcid: 8239446
Fischer, I. et al. Comparative characterization of decellularized renal scaffolds for tissue engineering. Biomed. Mater. 12(4), 045005 (2017).
doi: 10.1088/1748-605X/aa6c6d pubmed: 28396578
Ghorbani, F. et al. Detection of the residual concentration of sodium dodecyl sulfate in the decellularized whole rabbit kidney extracellular matrix. Cell Tissue Bank 23(1), 119–128 (2022).
doi: 10.1007/s10561-021-09921-z pubmed: 33909237
Leuning, D., Witjas, F., Maanaoui, M. et al. Vascular bioengineering of scaffolds derived from human discarded transplant kidneys using human pluripotent stem cell‐derived endothelium. Am. J. Transplant. 19, 1328-1343 (2018).
Peloso, A., Ferrario di Tor Vajana, A., Maiga Ferrario, B. et al. Creation and implantation of acellular rat renal ECM-based scaffolds. Organogenesis. 11, 58—74 (2015).
Bearak, J. et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: Estimates from a comprehensive model for 1990–2019. Lancet Glob. Health 8(9), e1152–e1161 (2020).
doi: 10.1016/S2214-109X(20)30315-6 pubmed: 32710833
Kajbafzadeh, A.-M., Javan-Farazmand, N., Monajemzadeh, M. & Baghayee, A. Determining the optimal decellularization and sterilization protocol for preparing a tissue scaffold of a human-sized liver tissue. Tissue Eng. Part C Methods 19(8), 642–651 (2012).
doi: 10.1089/ten.tec.2012.0334
Dijkman, P. E., Fioretta, E. S., Frese, L., Pasqualini, F. S. & Hoerstrup, S. P. Heart valve replacements with regenerative capacity. Transfus. Med. Hemother. 43(4), 282–290 (2016).
doi: 10.1159/000448181 pubmed: 27721704 pmcid: 5040925
Boroumand, S., Asadpour, S., Akbarzadeh, A., Faridi-Majidi, R. & Ghanbari, H. Heart valve tissue engineering: An overview of heart valve decellularization processes. Regener. Med. 13(1), 41–54 (2018).
doi: 10.2217/rme-2017-0061
Simpson, D. G. Dermal templates and the wound-healing paradigm: The promise of tissue regeneration. Expert Rev. Med. Dev. 3(4), 471–484 (2006).
doi: 10.1586/17434440.3.4.471
Dieckmann, C., Renner, R., Milkova, L. & Simon, J. C. Regenerative medicine in dermatology: Biomaterials, tissue engineering, stem cells, gene transfer and beyond. Exp. Dermatol. 19(8), 697–706 (2010).
doi: 10.1111/j.1600-0625.2010.01087.x pubmed: 20545761
Pokrywczynska, M., Adamowicz, J., Sharma, A. K. & Drewa, T. Human urinary bladder regeneration through tissue engineering—An analysis of 131 clinical cases. Exp. Biol. Med. 239(3), 264–271 (2014).
doi: 10.1177/1535370213517615
Serrano-Aroca, Á., Vera-Donoso, C. D. & Moreno-Manzano, V. Bioengineering approaches for bladder regeneration. Int. J. Mol. Sci. 19(6), 1796 (2018).
doi: 10.3390/ijms19061796 pubmed: 29914213 pmcid: 6032229
Jungebluth, P., Moll, G., Baiguera, S. & Macchiarini, P. Tissue-engineered airway: A regenerative solution. Clin. Pharmacol. Ther. 91(1), 81–93 (2012).
doi: 10.1038/clpt.2011.270 pubmed: 22130120
Rodriguez, M. M. Congenital anomalies of the kidney and the urinary tract (CAKUT). Fetal Pediatr. Pathol. 33(5–6), 293–320 (2014).
doi: 10.3109/15513815.2014.959678 pubmed: 25313840 pmcid: 4266037
Vanderheyden, T., Kumar, S., Fisk, N. M. Fetal renal impairment. In Presented at: Seminars in Neonatology (Elsevier, 2003).
Zolbin, M. M., Daghigh, F., Shojaie, L., Ekhtiyari, M., Kajbafzadeh, A.-M. Fetal lung tissue engineering. In Decellularization Methods of Tissue and Whole Organ in Tissue Engineering 17–33 (2021).
Turner, C. G. B. & Fauza, D. O. Fetal tissue engineering. Clin. Perinatol. 36(2), 473–488 (2009).
doi: 10.1016/j.clp.2009.03.005 pubmed: 19559332
Taylor, D. A., Caplan, A. L., Macchiarini, P. Ethics of Bioengineering Organs and Tissues (Taylor & Francis, 2014).
Trommelmans, L., Selling, J. & Dierickx, K. Ethical reflections on clinical trials with human tissue engineered products. J. Med. Ethics 34(9), e1–e1 (2008).
doi: 10.1136/jme.2007.022913 pubmed: 18757609
Oerlemans, A. J. M., Van Hoek, M. E. C., van Leeuwen, E., van der Burg, S. & Dekkers, W. J. M. Towards a richer debate on tissue engineering: A consideration on the basis of NEST-ethics. Sci. Eng. Ethics 19, 963–981 (2013).
doi: 10.1007/s11948-012-9419-y pubmed: 23229374
Liguori, G. R., Jeronimus, B. F., de Aquinas Liguori, T. T., Moreira, L. F. P. & Harmsen, M. C. Ethical issues in the use of animal models for tissue engineering: Reflections on legal aspects, moral theory, three rs strategies, and harm–benefit analysis. Tissue Eng. Part C Methods 23(12), 850–862 (2017).
doi: 10.1089/ten.tec.2017.0189 pubmed: 28756735
de Kanter, A.-F. J., Jongsma, K. R., Verhaar, M. C., Bredenoord, A. L. The ethical implications of tissue engineering for regenerative purposes: A systematic review. Tissue Eng. Part B Rev. 29(2), 167–187 (2023).
Shahraki, S. et al. Decellularization with triton X-100 provides a suitable model for human kidney bioengineering using human mesenchymal stem cells. Life Sci. 295, 120167 (2022).
doi: 10.1016/j.lfs.2021.120167 pubmed: 34822795
Ullah, I., Busch, J., Rabien, A. et al. Adult tissue extracellular matrix determines tissue specification of human iPSC‐derived embryonic stage mesodermal precursor cells. Adv. Sci. 7 (2020).
Ullah, I. et al. VEGF—Supplemented extracellular matrix is sufficient to induce endothelial differentiation of human iPSC. Biomaterials 216, 119283 (2019).
doi: 10.1016/j.biomaterials.2019.119283 pubmed: 31247481
Bombelli, S. et al. Nephrosphere-derived cells are induced to multilineage differentiation when cultured on human decellularized kidney scaffolds. Am. J. Pathol. 188(1), 184–195 (2018).
doi: 10.1016/j.ajpath.2017.09.012 pubmed: 29037855
Nagao, R. J. et al. Decellularized human kidney cortex hydrogels enhance kidney microvascular endothelial cell maturation and quiescence. Tissue Eng. Part A 22(19–20), 1140–1150 (2016).
doi: 10.1089/ten.tea.2016.0213 pubmed: 27481445 pmcid: 5073226

Auteurs

Mohamad Hossein Khosropanah (MH)

Pediatric Urology and Regenerative Medicine Research Center, Gene, Cell and Tissue Research Institute, Pediatric Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, No. 62, Dr. Qarib's St, Keshavarz Blvd, Tehran, 14194 33151, Iran.

Parham Torabinavid (P)

Pediatric Urology and Regenerative Medicine Research Center, Gene, Cell and Tissue Research Institute, Pediatric Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, No. 62, Dr. Qarib's St, Keshavarz Blvd, Tehran, 14194 33151, Iran.

Ashkan Azimzadeh (A)

Pediatric Urology and Regenerative Medicine Research Center, Gene, Cell and Tissue Research Institute, Pediatric Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, No. 62, Dr. Qarib's St, Keshavarz Blvd, Tehran, 14194 33151, Iran.

Saman Behboodi Tanourlouee (SB)

Pediatric Urology and Regenerative Medicine Research Center, Gene, Cell and Tissue Research Institute, Pediatric Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, No. 62, Dr. Qarib's St, Keshavarz Blvd, Tehran, 14194 33151, Iran.

Abdol-Mohammad Kajbafzadeh (AM)

Pediatric Urology and Regenerative Medicine Research Center, Gene, Cell and Tissue Research Institute, Pediatric Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, No. 62, Dr. Qarib's St, Keshavarz Blvd, Tehran, 14194 33151, Iran. kajbafzd@sina.tums.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH